Heuking advises Geratherm Medical AG on cash capital increase and downlisting to the Scale stock market segment
A team led by Cologne-based Partner Dr. Thorsten Kuthe legally advised Geratherm Medical AG on a cash capital increase and assisted the company in its downlisting to Frankfurt Stock Exchange’s Scale segment.
The entire transaction consists of several steps, starting with a capital increase under exclusion of subscription rights. The capital increase was fully subscribed by investor JotWe GmbH. The investor intends to submit a takeover bid for the purpose of revoking the admission of Geratherm Medical AG shares to trading on the regulated market of Frankfurt Stock Exchange (Prime Standard).
Geratherm Medical AG’s executive board and supervisory board intend to implement the downlisting to the Scale segment in coordination with major shareholder GMF Capital GmbH during the current fiscal year. The move will be made because the regulated market listing with its associated costs and complexities is no longer suitable for the company in terms of its structure and orientation. The future listing in the Scale segment, the segment for medium-sized companies on Frankfurt Stock Exchange, will continue to guarantee trading for shareholders.
Based in Geratal near Erfurt, Geratherm Medical is an internationally aligned medical technology company with the business divisions of Health Care Diagnostics, Medical Warming Systems, Cardio/Stroke, and Respiratory. Its roots are in medical temperature measurement. Geratherm has patent-protected basic technologies in all major business divisions. Geratherm has been quoted on the stock exchange since 2000 and approved for official trading on the Frankfurt Securities Exchange.
Counsel to Geratherm Medical AG
Heuking Kühn Lüer Wojtek:
Dr. Thorsten Kuthe (Lead, Capital Markets), Cologne
Anna Richter, LL.M.,
Magdalena Köster (all Capital Markets), all Cologne